quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:55:51·14h
ANALYSTRating
Equillium Inc. logo

Oppenheimer initiated coverage on Equillium with a new price target

EQ· Equillium Inc.
Health Care
Original source

Companies

  • EQ
    Equillium Inc.
    Health Care

Recent analyst ratings

  • Apr 23UpdateOppenheimer$7.00
  • Apr 16UpdateB. Riley Securities$6.00
  • Apr 14UpdateRaymond James$6.00
  • Apr 7UpdateCantor Fitzgerald$10.00
  • Mar 13UpdateRoth Capital$12.00
  • Feb 25UpdateStifel$5.00

Related

  • PR3d
    Equillium to Participate in Oppenheimer's 2026 Innovation on the Island Event
  • SEC6d
    SEC Form EFFECT filed by Equillium Inc.
  • ANALYST7d
    B. Riley Securities initiated coverage on Equillium with a new price target
  • SEC8d
    SEC Form DEFA14A filed by Equillium Inc.
  • SEC8d
    SEC Form DEF 14A filed by Equillium Inc.
  • ANALYST9d
    Raymond James initiated coverage on Equillium with a new price target
  • PR15d
    Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
  • SEC16d
    SEC Form S-3 filed by Equillium Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022